by sanhitamehta | Jul 21, 2023 | News&blogs, Uncategorized
Manchester MedTech company Averywell is set to start UK clinical trials on a ground breaking early detection test for lung cancer later this year. Averywell has developed a proprietary technology to detect microRNA biomarkers at the early onset of lung cancer –...
by sanhitamehta | Jan 23, 2023 | Uncategorized
We, at Averywell, are thrilled to announce our selection under the esteemed Global Entrepreneur Programme (GEP), a groundbreaking venture capital initiative designed to catapult innovative businesses to new heights of success. Renowned for its sterling reputation, the...
